A study comparing the retail drug prices between Northern Malaysia and Australia

Journal of Pharmaceutical Health Services Research

Volumn 3, Issue 2, 2012, Pages 103-107

  Hassali, Mohamed Azmi ^a   Shafie, Asrul Akmal ^a   Babar, Zaheer Ud Din ^b   Khan, Tahir Mehmood ^c  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c KING FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Australia; Comparison; Malaysia; Retail prescription price

Indexed keywords

AMLODIPINE BESYLATE; ATENOLOL; ATORVASTATIN; DICLOFENAC; GLIBENCLAMIDE PLUS METFORMIN; GLICLAZIDE; METOPROLOL; NIFEDIPINE; PRESCRIPTION DRUG; SALBUTAMOL; SIMVASTATIN;

ARTICLE; AUSTRALIA; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG COST; DRUG INDUSTRY; GOVERNMENT REGULATION; MALAYSIA; PRIORITY JOURNAL;

EID: 84860668917     PISSN: 17598885     EISSN: 17598893     Source Type: Journal    
DOI: 10.1111/j.1759-8893.2011.00080.x     Document Type: Article

References (30)

1. Smith C etal. Health spending growth slows in 2003. Health Aff [Millwood] 2005; 24: 185-194.
2. Nóbrega OT etal. Retail prices of essential drugs in Brazil: an international comparision. Rev Panam Salud Publica 2007; 22: 118-123.
3. Quick JD etal. Managing Drug Supply, 2nd edn. West Hartford, CT: Kumarian Press, 1997: 7-9.
4. Walid FG etal. Drug prices at pharmacies: are prices higher in poorer area? Health Serv Res 2009; 44: 606-617.
5. Babar ZU etal. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia. PLoS Med 2007; 4: 82.
6. Azmi IM, Alavi R. TRIPS, patents, technology transfer, foreign direct investment and the pharmaceutical industry in Malaysia. J World Intellect Property 2001; 4: 947-974.
7. Babar ZU etal. Effect of privatization of the drug distribution system on the prices of anti-infectives in Malaysia. J Pharm Finance Econ Policy 2004; 13: 3-26.
8. Babar ZU etal. A pricing analysis of cardiovascular and blood products after privatization of drug distribution system in Malaysia. J Pharm Finance Econ Policy 2005; 14: 3-25.
9. Hill SR. Medicine prices and Malaysia- untangling the medicines web. PLoS Med 2007; 4: 149.
10. Balasubramaniam K. Structural adjustment programs and privatisation of health care services: prospects and problems for health for all-now. Privatisation, Quality & Rights Proceedings of the Asia Pacific Consultation on Quality of Health Care Services; Madurai, India, 11-14 December 1996:4-33.
11. Izham M etal. Drug distribution system in Malaysia: the privatization of the general medical Store. National Conference on Privatization & Health Care Financing in Malaysia; Penang, Malaysia; 5-6 April 1997.
12. Moe S, Khin Saw Naing D. Health care financing: consumers' perspectives. Arch Pharm Pract 2011; 2: 47-49.
13. Chemist Warehouse. Chemist Warehouse profile. (accessed 28 August 2010).
14. Terry White Chemists. Terry White Chemists profile. (accessed 28 August 2010).
15. Mychemist Group.Mychemist Group profile 2008. (accessed 28 August 2008).
16. Hassali MA, Shafie AA. Price comparison between innovator and generic medicines sold by community pharmacies in the state of Penang, Malaysia. J Generic Med 2008; 6: 35-42.
17. Patricia MD, Jeong DK. International price comparisons for pharmaceuticals. Pharmacoeconomics 1998; 14: 115-128.
18. Babar ZU etal. A survey of medicine prices in Malaysia by using WHO/HAI methodology. Research Report. Penang, Malaysia: UCSI-USM, 2005.
19. Consumer Association of Penang. High Cost of Medical Care. The Money Book. Penang: Consumer Association of Penang, 2004: 184-185.
20. Australian Government Medicare Australia.Pharmacy mark-up. 2010. (accessed 28 August 2010).
21. Kolassa EM. Prices politic, and problems - a pricing philosophy. J Pharm Mark Pract 1997; 1: 21-27.
22. Mahmood M, Bukhari NI. Pharmaceutical Management and Marketing. Faisalabad: Tariq Academy, 2002: 115-144.
23. Wertheimer AI, Grumer SK. Overview of international pharmacy pricing. Pharmacoeconomics 1992; 2: 449-455.
24. Danzon PM. Making sense of drug prices. Regulation 2000; 23: 56-63.
25. Australian Government Productivity Commission. International pharmaceutical price differences, research report. Australian Government Productivity Commission, Canberra 2001. (accessed 20 August 2010).
26. Bloor K etal. Lessons from international experience in controlling pharmaceutical expenditures III: regulating industry. Br Med J 1996; 313: 33-35.
27. Ministry of Health (Malaysia): Pharmaceutical Services Division. National medicine policy. Ministry of Health (Malaysia): Pharmaceutical Services Division, 2009; 7: 1-24.
28. Danzon PM, Furukawa MF. Prices and availability of pharmaceuticals: evidence from nine countries. Health Aff [Millwood] 2003; 22: 521-536.
29. Danzon PM, Kim JD. International price comparisons for pharmaceuticals: Measurement and policy issue. Pharmacoeconomics 1998; 1: 115-128.
30. Richard GF. Prescription drug prices: why do some pay more than others do? Health Aff [Millwood] 2001; 20: 115-128.